Novel laboratory diagnostic tests for tuberculosis and their potential role in an integrated and tiered laboratory network

Tuberculosis
Akos Somoskövi

Abstract

Lack of laboratory capacity in high-burden countries presents a significant barrier in providing diagnosis and treatment to patients infected with HIV/AIDS, tuberculosis (TB), and malaria. Strengthening laboratory services in these settings via implementation of novel diagnostic tests is especially indispensable to battle against TB and MDR/XDR-TB. Novel TB diagnostic assays have to be applicable to field conditions, affordable and accessible to all patients at different levels of the tiered laboratory network. A functional laboratory network should be based on well-developed diagnostic platforms that can provide not only timely and adequate diagnosis but are simple to use, and easy to implement and sustain. The article is overviewing the latest developments of TB laboratory diagnostics such as smear microscopy, rapid growth detection and susceptibility testing and rapid molecular testing with focus on performance and applicability to diagnostic needs at different levels of the diagnostic network.

References

Apr 13, 2011·Clinical Microbiology Reviews·Linda M ParsonsJohn Nkengasong
Jun 3, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E C Böttger
Jul 8, 2011·The American Journal of Tropical Medicine and Hygiene·Caroline AsiimweMatt Berg
Jul 30, 2011·The Lancet Infectious Diseases·Jakko van IngenDick van Soolingen
Jan 14, 2012·The European Respiratory Journal·Enrico TortoliDaniela M Cirillo
Mar 17, 2012·Journal of Clinical Microbiology·Kevin P FennellyMoises Palaci
Sep 4, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julia V ErshovaJ Peter Cegielski
Mar 22, 2013·PloS One·Carole D MitnickMercedes C Becerra
Jul 19, 2013·The New England Journal of Medicine·Claudio U KöserSharon J Peacock

❮ Previous
Next ❯

Citations

Mar 2, 2016·The Journal of Antimicrobial Chemotherapy·Danila V ZimenkovDmitry A Gryadunov

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

© 2022 Meta ULC. All rights reserved